We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Shire is voluntarily recalling 344,000 Daytrana transdermal patches used to treat attention deficit hyperactivity disorder because some of the patches do not meet specifications.